Abstract
There is a worldwide increase in erectile dysfunction. The prevalence of ED increases with age. It increases by 10% per year of age; it increased from 2% in age group 18–38 years to 48% in the over 70 years and older. Organic causes account for a large proportion of erectile dysfunction in the elderly than in the young. The clinician should appreciate the sensitivity of the situation and must avoid creating any unnecessary embarrassment and anxiety. Male erectile dysfunction has a significant impact on health-related quality of life. The review discusses the prevalence and the causes followed by evaluation and clinical management.
Keywords
This is a preview of subscription content, log in via an institution.
References
Nicholson A, Moreira ED Jr, Shirai M, Bin Mohd Thambi MI, Galsser DB. Epidemiology of erectile dysfunction in four countries: cross International study of the prevalence and correlates of erectile dysfunction. Urology 2003;61::201–6.
Parazzini F, Munchini FF, Bortolotti A, Calabro A, Chatenond L, Colli E, et al. Frequency and determinants of erectile dysfunction in Italy. Eur Uol. 2000;37:43–49.
Weber MF, Smith DP, O’Connell DL, Patel M, de Souza OL, Sitas F, et al. Risk factors for erectile dysfunction in a cohort of 108477 Australian men. MJA. 2013;199(2):107–111.
Holden C, McLachlan RI, Pitt SM, Cummg R, Wittert G, Agius PA, et al. Men in Australia: Telephone Survey (MATEeS): a national survey of the reproductive health and concerns of middle- aged and older Australian men.Lancet 2005;366:218–220.
Lavelle P. Erectile dysfunction.aBC Health & Wellbeing. http://www.abc.net.au/health/library/stories/2008/02/14/2160484.htm retrieved 8/29/2008.
Chew KK, Earle CM, Stuckey BGA. Erectile dysfunction in general medical practice: prevalence and clinical correlations. Int Impot. Res. 2000;12:41–45.
O’Keefe M, Hunt DK. Assessment and treatment of impotence. N Med Clin N Am. 1995;79:415–434
Buffum J. Pharmacosexology update: prescription drugs and sexual function. J Psychoactive Drugs.1986;18:97–06.
Guay AT. Erectile dysfunction-are you prepared to discuss?. Postgrad Med. 1995;97:127–143.
Krane RJ, Goldstrin I, Saenz de Tejada I. Impotence. N Engl J Med. 1989:321:1648–1649.
Thase MG, Reynolds CF, Jennings JR. Nocturnal penile tumescence is diminished in depression in men. Biol Psychiatry. 1988;24:33–46.
Andresson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol. 2003;170(2Pt2):S6–13.
Kim ED. Erectile Dysfunction Workshop. Emedicine.medscape.com/article/444220-workshop#c7.
Kirby RS. Impotence: diagnosis and management of male erectile dysfunction. BMJ. 1994;308:957–61.
Fisher C, Gross J, Zuuch J. Cycle of penile erections synchronous with dreaming (REM) sleep. Arch Gen Psychiatry. 1953;12:29.
Karacan J, Goodenough DR, Shapiro A. Erection cycle during sleep in relation to dream anxiety. Arch Gen Psychiatry. 1966;15:183.
Lewis RW, Mayda J II. Diagnosis and treatment of vasculogenic impotence. Acta Chir Hung.1994;34:231–234.
UK Patient. Erectile dysfunction.patient.info/doctor/erectile-dysfunction
Ende J. Organic impotence. Chapter 187. Clinical Methods. The history, physical and laboratory examination. 3rd. Walker HK, Hall WD, Huest JW. Boston Butterworths,1990.
Priviero FB, Leite R, Webb RC, Teixeira CE. Neurophysiological basis of penile erection. Acta Pharmacol Sin. 2007;28(6):751–5.
De Busk RF, Pepine CJ, Glasser DB, Shpilsky A, De Riesthal H, Sweeney M, et al, Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am J Cardiol. 2004;93:147–153.
Shakir SAW, Wilton LW, Bochier A. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England. BMJ. 2001;322:651–652.
Cheitlin MD, Hutter Am, Brindis Rg, Ganz P, Kaul S, Russell RU, et al. Use of sildenafil in patients with cardiovascular disease. J Am Coll Cardiol. 1999;33:273–282.
Kloner R, Padma-Nathan H. Erectile dysfunction in patients with coronary artery disease. Int J Impotence Res. 2005;17:209–215.
Latini DM, Penson DF, Colwell HH, Lubeck DP, Mehta SS, et al. Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J Urol 2002;168(5):2086–91.
Althof SE. Quality of life and erectile dysfunction. Urology 2002;59:803–10.
Tomlinson J, Wright D. Impact of erectile dysfunction and its subsequent treatment with sildenafil: qualitative study. BMJ 2004;328:1037.
Impotence Association. Survey 1997. London: Taylor Nelson AGB Healthcare,1997.
Sexual Health. Consequences of erectile dysfunction. http://www.sexualhealthaustralia.com.au/consequences_of_ed.html. Accessed on 8 January 2017.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Nagaratnam, N., Nagaratnam, K., Cheuk, G. (2017). Male Sexual Dysfunction: Erectile Dysfunction (ED). In: Geriatric Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-32700-6_32-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-32700-6_32-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32700-6
Online ISBN: 978-3-319-32700-6
eBook Packages: Springer Reference MedicineReference Module Medicine